Abiopharma

News list

(75% Positive) Syros Pharmaceuticals, Inc. (SYRS) Announces Business Combination

Full text

News bot Oct. 3, 2025, 5:06 a.m.
📋 Syros Pharmaceuticals, Inc. (SYRS) - Business Combination

Filing Date: 2022-09-16

Accepted: 2022-09-16 16:15:57

Event Type: Business Combination
Event Details:
Syros Pharmaceuticals (SYRS) Announces Business Combination Syros Pharmaceuticals (SYRS) has entered into a strategic transaction. Transaction Details:
Transaction: pursuant to Syros to acquire TYME
Deal Value: $240 million
💼 Business Developments:
- Partnership
- Acquisition
- Licensing: Not available
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: Syros Pharmaceuticals
- CIK: 0001556263
- Ticker Symbol: SYRS
- Period End Date: 2022-09-15
- Document Type: 8-K